ReviewDer Nervenarzt2025
[Update on tic disorders and Tourette syndrome].
Review in Der Nervenarzt, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Association between leukotriene receptor antagonists and neuropsychiatric disorders: a systematic review and meta-analysis.Frontiers in pharmacology · 2026Pooled it
- [Taxonomy of anxiety disorders in comparison of ICD‑10 and ICD‑11. German version].Der Nervenarzt · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tic disorders are neurodevelopmental disorders characterized by involuntary motor and/or vocal expressions (tics). According to ICD-10 and ICD-11 classifications they are differentiated into transient (≤ 12 months) and chronic (> 12 months) tic disorders; the diagnosis of Tourette syndrome requires the presence of multiple motor tics and at least one vocal tic persisting for more than 1 year. Typical features of tics include onset in childhood, a premonitory urge, at least partial suppressibility and a rostrocaudal distribution. Differential diagnoses include other hyperkinetic neurological disorders as well as obsessive-compulsive symptoms, stereotypes and functional tic-like behaviors, the latter often presenting with a late, abrupt onset and predominantly complex expressions. Behavioral therapy is considered the first-line treatment for clinically relevant tics. Pharmacological treatment includes off-label use of dopamine antagonists, such as aripiprazole. Comorbidities are common and require targeted comanagement.
Indexed as
Identifiers
41201540What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.